ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,673.96
0.31%
Dow Jones
44,544.66
-0.75%
Gold vs US Dollar
2,798.49
0.00%
Brent Oil
76.385
0.00%
Bitcoin
100,158.03
-0.51%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) News

Immuron (IMRN)

Immuron Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMRN
DateTimeSourceHeadlineSymbolCompany
17/01/202513:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
17/01/202511:00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
15/01/202513:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
15/01/202511:00GlobeNewswire Inc.Immuron Announces New Research Collaboration targeting Antimicrobial ResistanceNASDAQ:IMRNImmuron Ltd
14/01/202513:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
14/01/202511:00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Trial UpdateNASDAQ:IMRNImmuron Ltd
10/01/202512:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
08/01/202512:48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/12/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
06/12/202414:17GlobeNewswire Inc.UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:IMRNImmuron Ltd
06/12/202413:35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
03/12/202413:35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
02/12/202411:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thNASDAQ:IMRNImmuron Ltd
22/11/202411:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
21/11/202423:33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNASDAQ:IMRNImmuron Ltd
18/11/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
14/11/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
29/10/202410:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
18/10/202410:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
16/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
16/10/202410:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceNASDAQ:IMRNImmuron Ltd
15/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
15/10/202410:00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
08/10/202411:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
04/10/202410:30GlobeNewswire Inc.NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyNASDAQ:IMRNImmuron Ltd
04/10/202410:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
01/10/202412:00Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:IMRNImmuron Ltd
26/09/202411:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
09/09/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
05/09/202415:54GlobeNewswire Inc.Immuron Plans Phase 2 Trial for IMM-529 following FDA reviewNASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Your Recent History

ASX
WBCHBP
Westpac Banking
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads